PMID- 27200496 OWN - NLM STAT- MEDLINE DCOM- 20170406 LR - 20211025 IS - 1522-7278 (Electronic) IS - 1520-4081 (Linking) VI - 32 IP - 3 DP - 2017 Mar TI - Epigallocatechin gallate sensitizes cisplatin-resistant oral cancer CAR cell apoptosis and autophagy through stimulating AKT/STAT3 pathway and suppressing multidrug resistance 1 signaling. PG - 845-855 LID - 10.1002/tox.22284 [doi] AB - Epigallocatechin gallate (EGCG) is a green tea polyphenol that presents anticancer activities in multiple cancer cells, but no available report was addressed for the underling molecular mechanism of cytotoxic impacts on drug-resistant oral squamous cell carcinoma cells. In the present study, the inhibitory effects of EGCG were experienced on cisplatin-resistant oral cancer CAR cells. EGCG inhibited cell viability in a time- and concentration-dependent manner by a sulforhodamine B (SRB) assay. EGCG induced CAR cell apoptosis and autophagy by 4',6-diamidino-2-phenylindole (DAPI) dye, acridine orange (AO) staining and green fluorescent protein (GFP)-tagged LC3B assay, respectively. EGCG also significantly enhanced caspase-9 and caspase-3 activities by caspase activity assay. EGCG markedly increased the protein levels of Bax, cleaved caspase-9, cleaved caspase-3, Atg5, Atg7, Atg12, Beclin-1, and LC3B-II, as well as significantly decreased the expression of Bcl-2, phosphorylated AKT (Ser473) and phosphorylation of STAT3 on Tyr705 by western blotting in CAR cells. Importantly, the protein and gene expression of multidrug resistance 1 (MDR1) were dose-dependently inhibited by EGCG. Overall, downregulation of MDR1 levels and alterations of AKT/STAT3 signaling contributed to EGCG-induced apoptosis and autophagy in CAR cells. Based on these results, EGCG has the potential for therapeutic effect on oral cancer and may be useful for long-term oral cancer prevention in the future. (c) 2016 Wiley Periodicals, Inc. Environ Toxicol 32: 845-855, 2017. CI - (c) 2016 Wiley Periodicals, Inc. FAU - Yuan, Chien-Han AU - Yuan CH AD - Department of Otolaryngology, Kaohsiung Armed Forces General Hospital, Kaohsiung, Taiwan. AD - Department of Otorhinolaryngology Head and Neck Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan. FAU - Horng, Chi-Ting AU - Horng CT AD - Kaohsiung Armed Forces General Hospital, Medical Education Center, Kaohsiung, Taiwan. AD - Institute of Biochemistry and Biotechnology, Chung Shan Medical University and Chung Shan Medical University Hospital, Taichung, Taiwan. FAU - Lee, Chiu-Fang AU - Lee CF AD - Kaohsiung Veterans General Hospital Pingtung Branch, Pingtung, Taiwan. FAU - Chiang, Ni-Na AU - Chiang NN AD - Kaohsiung Veterans General Hospital Pingtung Branch, Pingtung, Taiwan. FAU - Tsai, Fuu-Jen AU - Tsai FJ AD - Human Genetic Center, China Medical University Hospital, Taichung, Taiwan. AD - School of Post-Baccalaureate Chinese Medicine, China Medical University, Taichung, Taiwan. FAU - Lu, Chi-Cheng AU - Lu CC AD - School of Nutrition and Health Sciences, Taipei Medical University, Taipei, Taiwan. FAU - Chiang, Jo-Hua AU - Chiang JH AD - Department of Nursing, Chung-Jen Junior College of Nursing, Health Sciences and Management, Chiayi County, Taiwan. FAU - Hsu, Yuan-Man AU - Hsu YM AD - Department of Biological Science and Technology, China Medical University, Taichung, Taiwan. FAU - Yang, Jai-Sing AU - Yang JS AD - Department of Medical Research, China Medical University Hospital, China Medical University, Taichung, Taiwan. FAU - Chen, Fu-An AU - Chen FA AD - Department of Pharmacy and Master Program, Tajen University, Pingtung, Taiwan. LA - eng PT - Journal Article DEP - 20160520 PL - United States TA - Environ Toxicol JT - Environmental toxicology JID - 100885357 RN - 0 (ATP Binding Cassette Transporter, Subfamily B, Member 1) RN - 0 (Apoptosis Regulatory Proteins) RN - 0 (Autophagy-Related Proteins) RN - 0 (STAT3 Transcription Factor) RN - 8R1V1STN48 (Catechin) RN - BQM438CTEL (epigallocatechin gallate) RN - EC 2.7.11.1 (Proto-Oncogene Proteins c-akt) RN - EC 3.4.22.- (Caspase 3) RN - EC 3.4.22.- (Caspase 9) RN - Q20Q21Q62J (Cisplatin) SB - IM MH - ATP Binding Cassette Transporter, Subfamily B, Member 1/genetics/metabolism MH - Apoptosis/*drug effects MH - Apoptosis Regulatory Proteins/metabolism MH - Autophagy/*drug effects MH - Autophagy-Related Proteins/metabolism MH - Caspase 3/metabolism MH - Caspase 9/metabolism MH - Catechin/*analogs & derivatives/pharmacology MH - Cell Line, Tumor MH - Cisplatin/pharmacology/*toxicity MH - Down-Regulation/drug effects MH - Humans MH - Microscopy, Fluorescence MH - Mouth Neoplasms/metabolism/pathology MH - Phosphorylation/drug effects MH - Proto-Oncogene Proteins c-akt/metabolism MH - STAT3 Transcription Factor/metabolism MH - Signal Transduction/*drug effects OTO - NOTNLM OT - AKT/STAT3 signaling OT - MDR1 OT - apoptosis OT - autophagy OT - epigallocatechin gallate EDAT- 2016/05/21 06:00 MHDA- 2017/04/07 06:00 CRDT- 2016/05/21 06:00 PHST- 2016/03/31 00:00 [received] PHST- 2016/04/21 00:00 [revised] PHST- 2016/04/30 00:00 [accepted] PHST- 2016/05/21 06:00 [pubmed] PHST- 2017/04/07 06:00 [medline] PHST- 2016/05/21 06:00 [entrez] AID - 10.1002/tox.22284 [doi] PST - ppublish SO - Environ Toxicol. 2017 Mar;32(3):845-855. doi: 10.1002/tox.22284. Epub 2016 May 20.